Hongsai Chen1,2,3,4, Weidong Zhu1,2,3,4, Xiye Li1,2,3,4, Lu Xue1,2,3,4, Zhaoyan Wang5,6,7, Hao Wu8,9,10. 1. Department of Otolaryngology Head and Neck Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2. Department of Otolaryngology Head and Neck Surgery, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhi-Zao-Ju Road, Shanghai, 200011, China. 3. Ear Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 4. Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai, China. 5. Department of Otolaryngology Head and Neck Surgery, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhi-Zao-Ju Road, Shanghai, 200011, China. wzyent@126.com. 6. Ear Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. wzyent@126.com. 7. Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai, China. wzyent@126.com. 8. Department of Otolaryngology Head and Neck Surgery, The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639, Zhi-Zao-Ju Road, Shanghai, 200011, China. wuhao622@sina.cn. 9. Ear Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. wuhao622@sina.cn. 10. Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai, China. wuhao622@sina.cn.
Abstract
PURPOSE: In addition to genetic alterations, the importance of a CpG island methylator phenotype, characterized by methylation of multiple tumour-suppressor genes (TSGs), has been acknowledged in many cancer types. This study was done to determine the impact of genetic and epigenetic patterns on the clinical characteristics of the head and neck paragangliomas (HNPGLs). METHODS: The retrospective study examined a series of 37 patients with HNPGLs who underwent surgical resection between 2010 and 2015. The mutations in the succinate dehydrogenase (SDH) genes were detected using direct DNA sequencing. Aberrant hypermethylation of the CpG islands of a panel of ten TSGs was also analysed using methylation-specific PCR. RESULTS: Direct sequencing demonstrated the presence of germline SDH mutations in ten HNPGLs. Comparisons of clinical features between mutated and non-mutated HNPGLs established an association of SDH mutations with progressive phenotypes, including an earlier formation, multiple lesions, or malignancy. There was also a significant correlation between the presence of SDH mutations and the number of TSGs methylated in HNPGLs. The SDH-related tumours were therefore more likely to suffer from a CpG island methylator phenotype. Four differentially methylated TSGs in mutated tumours vs non-mutated counterparts were identified with inefficient expression through Real-Time PCR analysis. CONCLUSIONS: Our results suggested that epigenetic inactivation on multiple TSGs may serve as a key mechanism for the progressive behaviors of SDH-mutated HNPGLs. Thus, an interplay between genetic status, epigenetic alterations, and clinical features might be established in the disease.
PURPOSE: In addition to genetic alterations, the importance of a CpG island methylator phenotype, characterized by methylation of multiple tumour-suppressor genes (TSGs), has been acknowledged in many cancer types. This study was done to determine the impact of genetic and epigenetic patterns on the clinical characteristics of the head and neck paragangliomas (HNPGLs). METHODS: The retrospective study examined a series of 37 patients with HNPGLs who underwent surgical resection between 2010 and 2015. The mutations in the succinate dehydrogenase (SDH) genes were detected using direct DNA sequencing. Aberrant hypermethylation of the CpG islands of a panel of ten TSGs was also analysed using methylation-specific PCR. RESULTS: Direct sequencing demonstrated the presence of germline SDH mutations in ten HNPGLs. Comparisons of clinical features between mutated and non-mutated HNPGLs established an association of SDH mutations with progressive phenotypes, including an earlier formation, multiple lesions, or malignancy. There was also a significant correlation between the presence of SDH mutations and the number of TSGs methylated in HNPGLs. The SDH-related tumours were therefore more likely to suffer from a CpG island methylator phenotype. Four differentially methylated TSGs in mutated tumours vs non-mutated counterparts were identified with inefficient expression through Real-Time PCR analysis. CONCLUSIONS: Our results suggested that epigenetic inactivation on multiple TSGs may serve as a key mechanism for the progressive behaviors of SDH-mutated HNPGLs. Thus, an interplay between genetic status, epigenetic alterations, and clinical features might be established in the disease.
Authors: E F Hensen; M D Siemers; J C Jansen; E P M Corssmit; J A Romijn; C M J Tops; A G L van der Mey; P Devilee; C J Cornelisse; J P Bayley; A H J T Vriends Journal: Clin Endocrinol (Oxf) Date: 2011-11 Impact factor: 3.478
Authors: Toshinori Hinoue; Daniel J Weisenberger; Christopher P E Lange; Hui Shen; Hyang-Min Byun; David Van Den Berg; Simeen Malik; Fei Pan; Houtan Noushmehr; Cornelis M van Dijk; Rob A E M Tollenaar; Peter W Laird Journal: Genome Res Date: 2011-06-09 Impact factor: 9.043
Authors: Nelly Burnichon; Alberto Cascón; Francesca Schiavi; Nicole Paes Morales; Iñaki Comino-Méndez; Nasséra Abermil; Lucía Inglada-Pérez; Aguirre A de Cubas; Laurence Amar; Marta Barontini; Sandra Bernaldo de Quirós; Jérôme Bertherat; Yves-Jean Bignon; Marinus J Blok; Sara Bobisse; Salud Borrego; Maurizio Castellano; Philippe Chanson; María-Dolores Chiara; Eleonora P M Corssmit; Mara Giacchè; Ronald R de Krijger; Tonino Ercolino; Xavier Girerd; Encarna B Gómez-García; Alvaro Gómez-Graña; Isabelle Guilhem; Frederik J Hes; Emiliano Honrado; Esther Korpershoek; Jacques W M Lenders; Rocío Letón; Arjen R Mensenkamp; Anna Merlo; Luigi Mori; Arnaud Murat; Peggy Pierre; Pierre-François Plouin; Tamara Prodanov; Miguel Quesada-Charneco; Nan Qin; Elena Rapizzi; Victoria Raymond; Nicole Reisch; Giovanna Roncador; Macarena Ruiz-Ferrer; Frank Schillo; Alexander P A Stegmann; Carlos Suarez; Elisa Taschin; Henri J L M Timmers; Carli M J Tops; Miguel Urioste; Felix Beuschlein; Karel Pacak; Massimo Mannelli; Patricia L M Dahia; Giuseppe Opocher; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo Journal: Clin Cancer Res Date: 2012-03-27 Impact factor: 12.531
Authors: Janos Geli; Nimrod Kiss; Mohsen Karimi; Jia-Jing Lee; Martin Bäckdahl; Tomas J Ekström; Catharina Larsson Journal: Clin Cancer Res Date: 2008-05-01 Impact factor: 12.531
Authors: N B Kiss; J Geli; F Lundberg; C Avci; D Velazquez-Fernandez; J Hashemi; G Weber; A Höög; T J Ekström; M Bäckdahl; C Larsson Journal: Endocr Relat Cancer Date: 2008-06 Impact factor: 5.678
Authors: Jonathan A Forbes; Andrea A Brock; Mayshan Ghiassi; Reid C Thompson; David S Haynes; Betty S Tsai Journal: Neurosurg Focus Date: 2012-08 Impact factor: 4.047